private:zygatechnology
|
564931
|
Jun 4th, 2019 12:00AM
|
Zyga
|
1.2K
|
21.00
|
Open
|
Medical Devices
|
Jun 4th, 2019 04:54PM
|
Jun 4th, 2019 04:54PM
|
Zyga was founded to develop and market innovative, minimally invasive surgical solutions to treat common but underserved painful conditions of the spine. The company is currently marketing the SImmetry Sacroiliac Joint Fusion System and is developing the Glyder Facet Restoration Device. Facetogenic and Sacroiliac joint pain are responsible for up to 30% and 20% of low back pain, respectively. These conditions are largely untreated surgically due to the lack of effective surgical solutions. Patients who suffer from these conditions typically receive palliative care such as steroid injections which provide temporary relief but require repeat treatments year after year.
|
Open
|
Sacroiliac Joint Fusion, Facet Joint Restoration, Spine Medical Device, Minimally Invasive Surgery
|
Open
|
5600 Rowland Road, Suite 200
|
Minnetonka
|
MN
|
US
|
55343
|
|
Zyga Technology
|
Health Care
|
Health Care Equipment & Services
|
private:zygatechnology
|
564931
|
Feb 17th, 2018 12:00AM
|
Zyga
|
1.1K
|
29.00
|
Open
|
Medical Devices
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Zyga was founded to develop and market innovative, minimally invasive surgical solutions to treat common but underserved painful conditions of the spine. The company is currently marketing the SImmetry Sacroiliac Joint Fusion System and is developing the Glyder Facet Restoration Device. Facetogenic and Sacroiliac joint pain are responsible for up to 30% and 20% of low back pain, respectively. These conditions are largely untreated surgically due to the lack of effective surgical solutions. Patients who suffer from these conditions typically receive palliative care such as steroid injections which provide temporary relief but require repeat treatments year after year.
|
|
|
|
|
|
|
|
|
|
Zyga Technology
|
Health Care
|
Health Care Equipment & Services
|
private:zygatechnology
|
564931
|
Feb 16th, 2018 12:00AM
|
Zyga
|
1.1K
|
29.00
|
Open
|
Medical Devices
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Zyga was founded to develop and market innovative, minimally invasive surgical solutions to treat common but underserved painful conditions of the spine. The company is currently marketing the SImmetry Sacroiliac Joint Fusion System and is developing the Glyder Facet Restoration Device. Facetogenic and Sacroiliac joint pain are responsible for up to 30% and 20% of low back pain, respectively. These conditions are largely untreated surgically due to the lack of effective surgical solutions. Patients who suffer from these conditions typically receive palliative care such as steroid injections which provide temporary relief but require repeat treatments year after year.
|
|
|
|
|
|
|
|
|
|
Zyga Technology
|
Health Care
|
Health Care Equipment & Services
|
private:zygatechnology
|
564931
|
Feb 15th, 2018 12:00AM
|
Zyga
|
1.1K
|
29.00
|
Open
|
Medical Devices
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Zyga was founded to develop and market innovative, minimally invasive surgical solutions to treat common but underserved painful conditions of the spine. The company is currently marketing the SImmetry Sacroiliac Joint Fusion System and is developing the Glyder Facet Restoration Device. Facetogenic and Sacroiliac joint pain are responsible for up to 30% and 20% of low back pain, respectively. These conditions are largely untreated surgically due to the lack of effective surgical solutions. Patients who suffer from these conditions typically receive palliative care such as steroid injections which provide temporary relief but require repeat treatments year after year.
|
|
|
|
|
|
|
|
|
|
Zyga Technology
|
Health Care
|
Health Care Equipment & Services
|
private:zygatechnology
|
564931
|
Feb 14th, 2018 12:00AM
|
Zyga
|
1.1K
|
29.00
|
Open
|
Medical Devices
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Zyga was founded to develop and market innovative, minimally invasive surgical solutions to treat common but underserved painful conditions of the spine. The company is currently marketing the SImmetry Sacroiliac Joint Fusion System and is developing the Glyder Facet Restoration Device. Facetogenic and Sacroiliac joint pain are responsible for up to 30% and 20% of low back pain, respectively. These conditions are largely untreated surgically due to the lack of effective surgical solutions. Patients who suffer from these conditions typically receive palliative care such as steroid injections which provide temporary relief but require repeat treatments year after year.
|
|
|
|
|
|
|
|
|
|
Zyga Technology
|
Health Care
|
Health Care Equipment & Services
|
private:zygatechnology
|
564931
|
Feb 13th, 2018 12:00AM
|
Zyga
|
1.1K
|
29.00
|
Open
|
Medical Devices
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Zyga was founded to develop and market innovative, minimally invasive surgical solutions to treat common but underserved painful conditions of the spine. The company is currently marketing the SImmetry Sacroiliac Joint Fusion System and is developing the Glyder Facet Restoration Device. Facetogenic and Sacroiliac joint pain are responsible for up to 30% and 20% of low back pain, respectively. These conditions are largely untreated surgically due to the lack of effective surgical solutions. Patients who suffer from these conditions typically receive palliative care such as steroid injections which provide temporary relief but require repeat treatments year after year.
|
|
|
|
|
|
|
|
|
|
Zyga Technology
|
Health Care
|
Health Care Equipment & Services
|
private:zygatechnology
|
564931
|
Feb 12th, 2018 12:00AM
|
Zyga
|
1.1K
|
29.00
|
Open
|
Medical Devices
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Zyga was founded to develop and market innovative, minimally invasive surgical solutions to treat common but underserved painful conditions of the spine. The company is currently marketing the SImmetry Sacroiliac Joint Fusion System and is developing the Glyder Facet Restoration Device. Facetogenic and Sacroiliac joint pain are responsible for up to 30% and 20% of low back pain, respectively. These conditions are largely untreated surgically due to the lack of effective surgical solutions. Patients who suffer from these conditions typically receive palliative care such as steroid injections which provide temporary relief but require repeat treatments year after year.
|
|
|
|
|
|
|
|
|
|
Zyga Technology
|
Health Care
|
Health Care Equipment & Services
|
private:zygatechnology
|
564931
|
Feb 11th, 2018 12:00AM
|
Zyga
|
1.1K
|
29.00
|
Open
|
Medical Devices
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Zyga was founded to develop and market innovative, minimally invasive surgical solutions to treat common but underserved painful conditions of the spine. The company is currently marketing the SImmetry Sacroiliac Joint Fusion System and is developing the Glyder Facet Restoration Device. Facetogenic and Sacroiliac joint pain are responsible for up to 30% and 20% of low back pain, respectively. These conditions are largely untreated surgically due to the lack of effective surgical solutions. Patients who suffer from these conditions typically receive palliative care such as steroid injections which provide temporary relief but require repeat treatments year after year.
|
|
|
|
|
|
|
|
|
|
Zyga Technology
|
Health Care
|
Health Care Equipment & Services
|
private:zygatechnology
|
564931
|
Feb 10th, 2018 12:00AM
|
Zyga
|
1.1K
|
29.00
|
Open
|
Medical Devices
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Zyga was founded to develop and market innovative, minimally invasive surgical solutions to treat common but underserved painful conditions of the spine. The company is currently marketing the SImmetry Sacroiliac Joint Fusion System and is developing the Glyder Facet Restoration Device. Facetogenic and Sacroiliac joint pain are responsible for up to 30% and 20% of low back pain, respectively. These conditions are largely untreated surgically due to the lack of effective surgical solutions. Patients who suffer from these conditions typically receive palliative care such as steroid injections which provide temporary relief but require repeat treatments year after year.
|
|
|
|
|
|
|
|
|
|
Zyga Technology
|
Health Care
|
Health Care Equipment & Services
|
private:zygatechnology
|
564931
|
Feb 9th, 2018 12:00AM
|
Zyga
|
1.1K
|
29.00
|
Open
|
Medical Devices
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
Zyga was founded to develop and market innovative, minimally invasive surgical solutions to treat common but underserved painful conditions of the spine. The company is currently marketing the SImmetry Sacroiliac Joint Fusion System and is developing the Glyder Facet Restoration Device. Facetogenic and Sacroiliac joint pain are responsible for up to 30% and 20% of low back pain, respectively. These conditions are largely untreated surgically due to the lack of effective surgical solutions. Patients who suffer from these conditions typically receive palliative care such as steroid injections which provide temporary relief but require repeat treatments year after year.
|
|
|
|
|
|
|
|
|
|
Zyga Technology
|
Health Care
|
Health Care Equipment & Services
|